Zobrazeno 1 - 10
of 460
pro vyhledávání: '"C. C. Johnston"'
Autor:
C C, JOHNSTON
Publikováno v:
Kentucky medical journal. 45(1)
Autor:
P D, Miller, S L, Bonnick, C C, Johnston, M, Kleerekoper, R L, Lindsay, L M, Sherwood, E S, Siris
Publikováno v:
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. 1(3)
Lower cost, portable, peripheral bone mass measurement devices are being increasingly utilized for widespread bone mass testing. These devices are being placed in traditional medical settings as well as nontraditional settings, such as pharmacies and
Publikováno v:
Neurology. 57(12)
Autor:
C C, Johnston
Publikováno v:
Journal of the South Carolina Medical Association (1975). 97(3)
Autor:
C C, Johnston
Publikováno v:
Health news (Waltham, Mass.). 6(9)
Autor:
I, Takacs, D L, Koller, M, Peacock, J C, Christian, S L, Hui, P M, Conneally, C C, Johnston, T, Foroud, M J, Econs
Publikováno v:
The Journal of clinical endocrinology and metabolism. 84(12)
A major determinant of the risk for osteoporosis in later life is bone mineral density (BMD) attained during early adulthood. BMD is a complex trait that presumably is influenced by multiple genes. Insulin-like growth factor I (IGF-I) is an attractiv
Publikováno v:
Biology of the neonate. 76(2)
The purpose of this study was to investigate if cries from preterm neonates would reflect changes in pain intensity following interventions. The cries from 25 preterm neonates from an original sample of 122 were audiorecorded while the infant was und
Publikováno v:
Menopause (New York, N.Y.). 5(2)
As part of a study on hormones and bone density in older women, we measured a number of steroid and polypeptide hormones at 4- to 6-month intervals in 32 women over a 10-year period.All women were postmenopausal during this time and all measurements
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(2)
This double-blind, placebo-controlled study was undertaken to determine 1) the efficacy of oral risedronate for prevention of bone loss in healthy, early postmenopausal patients with normal bone mass, 2) the effect on bone mass when treatment was sto
Autor:
D B, Karpf, D R, Shapiro, E, Seeman, K E, Ensrud, C C, Johnston, S, Adami, S T, Harris, A C, Santora, L J, Hirsch, L, Oppenheimer, D, Thompson
Publikováno v:
JAMA. 277(14)
To evaluate the effect of treatment with alendronate sodium, a potent aminobisphosphonate, on the incidence of nonvertebral fractures in postmenopausal women with osteoporosis.Published data and data on file at Merck Research Laboratories.All complet